2005/413/EC: Commission Decision of 30 May 2005 amending Decisions 2004/696/EC and 2004/863/EC on the Community's financial contribution to the TSE eradication and monitoring programmes for 2005 (notified under document number C(2005) 1550)
Date: 2005-05-30
Institutions: European Commission
Subjects: EU financing, EU programme, animal disease, bovine spongiform encephalopathy, disease prevention, veterinary inspection

L 141/24

EN

Official Journal of the European Union

4.6.2005

II

(Acts whose publication is not obligatory)

COMMISSION

COMMISSION DECISION

of 30 May 2005

amending Decisions 2004/696/EC and 2004/863/EC on the Community's financial contribution to
the TSE eradication and monitoring programmes for 2005

(notified under document number C(2005) 1550)

(2005/413/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

first case of BSE in a small ruminant under natural
conditions.

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular
Article 24(5) and (6) thereof,

Whereas:

(1)

(2)

(3)

Commission Decision 2004/696/EC of 14 October 2004
on the list of programmes for the eradication and the
monitoring of certain TSEs qualifying for a financial
contribution from the Community in 2005 (2) sets out
the list of such programmes, as well as the proposed rate
and amount of the contribution for each programme.

Commission Decision 2004/863/EC of 30 November
2004 approving the TSE eradication and monitoring
programmes of certain Member States for 2005 and
the Community’s financial contri-
fixing the level of
bution (3).

On 28 January 2005, a Community expert panel, chaired
by the Community Reference laboratory for TSEs (CRL),
confirmed the detection of bovine spongiform encepha-
lopathy (BSE) in a goat slaughtered in France. It was the

(4)

(5)

(6)

In its statement of 28 January 2005, the Scientific Panel
on Biological Hazards of
the European Food Safety
Authority (EFSA) stressed that the significance of that
single case of BSE infection in a goat in France is yet
to be assessed. In order to do so, the EFSA indicated that
the results of an increased monitoring of TSEs in goats
are essential.

to

that

response

statement, Regulation

In
(EC)
No 999/2001 of the European Parliament and of the
Council of 22 May 2001 laying down rules for the
prevention, control and eradication of certain trans-
missible spongiform encephalopathies (4), as amended
by Commission Regulation (EC) No 214/2005 (5),
introduced a new programme for the monitoring of
starting from 11 February
TSE in caprine animals
2005. Under
the
numbers of healthy slaughter and dead-on-farm caprine
animals to be tested have been substantially increased.

that new monitoring programme,

Due to the particularities of the goat meat sector, the
limited value of goats above 18 months of age for
slaughter purposes, and in the light of the importance
of an effective implementation of the increased moni-
toring to assess
the prevalence of BSE in caprine
it is appropriate to increase the amount per
animals,
test
to be reimbursed to the Member States by the
Community up to a maximum amount of EUR 30 per
rapid test performed in caprine animals.

(1) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation

(EC) No 806/2003 (OJ L 122, 16.5.2003, p. 1).

(2) OJ L 316, 15.10.2004, p. 91.
(3) OJ L 370, 17.12.2004, p. 82.

(4) OJ L 147, 31.5.2001, p. 1. Regulation as

last amended by
Commission Regulation (EC) 260/2005 (OJ L 46, 17.2.2005, p. 9).

(5) OJ L 37, 10.2.2005, p. 9.

4.6.2005

EN

Official Journal of the European Union

L 141/25

(7)

(8)

(9)

In addition, Regulation (EC) 999/2001, as amended
Commission Regulation (EC) No 36/2005 (1) sets out
the compulsory systematic discriminatory testing to
differentiate BSE from scrapie in all TSE cases detected
in ovine and caprine animals to apply from 14 January
2005. That measure should be considered as eligible for
the Community’s financial contribution to the TSE moni-
toring and eradication programmes
in the Member
States.

ruminants

In the light of the importance to assess the prevalence of
BSE in small
achievement of
Community objectives in the field of public and animal
health it is appropriate to reimburse 100% of the costs
paid by the Member States for the primary molecular
tests to differentiate BSE from scrapie.

the

for

Therefore, it is necessary to revise the maximum amount
of
financial participation by the Community for each
programme, as set out in Decisions 2004/696/EC and
2004/863/EC.

financial

including

contribution,

(10) Decision 2004/863/EC sets out the conditions for the
Community’s
the
forwarding of a monthly report to the Commission by
the concerned Member States on the progress of the TSE
monitoring programmes and the cost paid. The Annex to
that sets out the costs to be paid. That Annex should be
amended to take account of amendments to Annexes III
and X to Regulation (EC) No 999/2001, as amended by
Regulation (EC) No 36/2005 and No 214/2005.

(11) Decisions

2004/696/EC and

2004/863/EC should

therefore be amended accordingly.

(12)

The measures provided for
accordance with
Committee of the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

HAS ADOPTED THIS DECISION:

Article 1

2.

in Article 2(2),
1 736 000’;

3.

in Article 3(2),
2 426 000’;

4.

in Article 4(2),
15 170 000’;

5.

in Article 5(2),
294 000’;

6.

in Article 6(2),
1 487 000’;

7.

in Article 7(2),
8 846 000’;

8.

in Article 8(2),
29 755 000’;

9.

in Article 9(2),
6 172 000’;

‘EUR 1 700 000’

is replaced by ‘EUR

‘EUR 2 375 000’

is replaced by ‘EUR

‘EUR 15 020 000’

is replaced by ‘EUR

‘EUR 290 000’

is

replaced by ‘EUR

‘EUR 585 000’

is

replaced by ‘EUR

‘EUR 4 780 000’

is replaced by ‘EUR

‘EUR 24 045 000’

is replaced by ‘EUR

‘EUR 6 170 000’

is replaced by ‘EUR

10.

in Article 10(2),
8 677 000’;

11.

in Article 11(2),
353 000’;

12.

in Article 12(2),
836 000’;

13.

in Article 13(2),
155 000’;

14.

in Article 14(2),
1 184 000’;

‘EUR 6 660 000’

is replaced by ‘EUR

‘EUR 85 000’

is

replaced by ‘EUR

‘EUR 835 000’

is

replaced by ‘EUR

‘EUR 145 000’

is

replaced by ‘EUR

‘EUR 1 085 000’

is replaced by ‘EUR

15.

in Article 15(2), ‘EUR 35 000’ is replaced by ‘EUR 36 000’;

Annex I to Decision 2004/696/EC is amended in accordance
with Annex I to this Decision.

16.

in Article 16(2),
4 510 000’;

‘EUR 4 270 000’

is replaced by ‘EUR

Article 2

Decision 2004/863/EC is amended as follows:

1.

in Article 1(2),
3 586 000’;

‘EUR 3 550 000’

is replaced by ‘EUR

(1) OJ L 10, 13.1.2005, p. 9.

17.

in Article 17(2),
2 076 000’;

18.

in Article 18(2),
1 480 000’;

19.

in Article 19(2),
444 000’;

‘EUR 1 920 000’

is replaced by ‘EUR

‘EUR 1 135 000’

is replaced by ‘EUR

‘EUR 435 000’

is

replaced by ‘EUR

L 141/26

EN

Official Journal of the European Union

4.6.2005

20.

in Article 20(2),
1 170 000’;

21.

in Article 21(2),
313 000’;

22.

in Article 22(2),
5 690 000’;

‘EUR 1 160 000’

is replaced by ‘EUR

‘EUR 305 000’

is

replaced by ‘EUR

‘EUR 5 570 000’

is replaced by ‘EUR

23. Article 23 is replaced by the following:

‘Article 23

The Community's financial contribution for the TSE moni-
toring programmes referred to in Articles 1 to 22 shall be
at the rate of 100 % of the cost paid, value added tax
excluded, by the concerned Member States for the tests
performed, subject to:

(a) a maximum amount of EUR 8 per test, for tests carried
out from 1 January to 31 December 2005 in bovine
and ovine animals referred to in Annex III to Regu-
lation (EC) No 999/2001;

(b) a maximum amount of EUR 30 per test,

for tests
carried out from 1 January to 31 December 2005 in
caprine animals referred to in Annex III to Regulation
(EC) No 999/2001;

discriminatory

(c) a maximum amount of EUR 145 per test, for primary
molecular
from
14 January 2005 to 31 December 2005 as referred
to in Annex X, Chapter C, point 3.2(c)(i) to Regulation
(EC) No 999/2001.’;

carried out

tests

24. the Annex is replaced by Annex II to this Decision.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 30 May 2005.

For the Commission

Markos KYPRIANOU
Member of the Commission

4.6.2005

EN

Official Journal of the European Union

L 141/27

Annex I to Decision 2004/696/EC is replaced by the following:

ANNEX I

‘ANNEX I

List of programmes for the monitoring of TSEs

Rate and maximum amount of the Community financial contribution

Disease

Member State

Rate tests (1) performed

Maximum amount

(in EUR)

TSEs

Austria

Belgium
Cyprus

Czech Republic

Denmark
Estonia

Finland

France
Germany

Greece

Hungary

Ireland
Italy

Lithuania

Luxembourg
Malta

Netherlands

Portugal
Slovenia

Spain

Sweden
United Kingdom

100 %

100 %
100 %

100 %

100 %
100 %

100 %

100 %
100 %

100 %

100 %

100 %
100 %

100 %

100 %
100 %

100 %

100 %
100 %

100 %

100 %
100 %

2 076 000

3 586 000
353 000

1 736 000

2 426 000
294 000

1 170 000

29 755 000
15 170 000

1 487 000

1 184 000

6 172 000
8 677 000

836 000

155 000
36 000

4 510 000

1 480 000
444 000

8 846 000

313 000
5 690 000

(1) Rapid tests and primary molecular tests.’

Total

96 396 000

L 141/28

EN

Official Journal of the European Union

4.6.2005

ANNEX II

‘ANNEX

TSE monitoring

Member State:

Month:

Year:

Tests on bovine animals

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex III, Chapter A, Part I,
points 2.1, 3 and 4.1 to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part I,
points 2.2, 4.2 and 4.3 to Regulation (EC) No 999/2001

Total

Tests on ovine animals

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex III, Chapter A, Part II,
point 2(a) to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II,
point 3 to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II,
point 5 to Regulation (EC) No 999/2001

Total

Tests on caprine animals

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex III, Chapter A, Part II,
point 2(b) to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II,
point 3 to Regulation (EC) No 999/2001

Tests on animals referred to in Annex III, Chapter A, Part II,
point 5 to Regulation (EC) No 999/2001

Total

Primary molecular testing with a discriminatory immuno-blotting

Number of tests

Unit cost

Total cost

Tests on animals referred to in Annex X, Chapter C,
point 3.2 (c) (i) to Regulation (EC) No 999/2001’